baber/WOPTO huggingface dataset:
Patent EP-2034948-A1 (EP)
Title: Composites renforces de fibres et procede pour leur fabrication
Inventor: LASSILA LIPPO V J
IPC: A61K6/884
Filed: 2007-06-29
Abstract: L'invention concerne des composites renforcés de fibres, en particulier des composites à application orientée utiles dans les applications/appareils dentaires et médicaux, par exemple des composites dentaires renforcés de fibres et un procédé pour leur fabrication. En particulier, l'invention concerne des résines composites de restauration renforcées de fibres de verre disposées aléatoirement, une matrice de polymère en réseau de semi-interpénétré et leur utilisation dans des applications dentaires telles que le remplissage de cavités, les composites de noyau, les composites de couronne et bridge provisoires et semi-permanents, les ciments et les adhésifs.
Patent EP-2067810-A1 (EP)
Inventor: YOKOTA KOUICHI
IPC: G02B5/30
Filed: 2007-07-31
Abstract: The present invention provides a cation-polymerizable resin composition comprising (A) a multi-branched polyether polyol obtained from a ring-opening reaction of (a1) a hydroxyalkyloxetane and (a2) an epoxy compound having one epoxy group, (B) an alicyclic epoxy compound having at least two alicyclic epoxy groups, and (C) an acid generator, which may be used in various uses including, for example, an adhesive agent or tackiness agent for optical elements, various kinds of coating agents and the like.
Patent EP-2047513-A1 (EP)
Inventor: TREDWELL TIMOTHY JOHN
IPC: H01L51/00
Filed: 2007-07-16
Abstract: A method of manufacturing an electronic device (10) provides a substrate (20) that has a plastic material. A particulate material (16) is embedded in at least one surface of the substrate. A layer of thin-film semiconductor material is deposited onto the substrate (20).
Patent EP-2030018-A1 (EP)
Inventor: KORNBLAU STEVEN
IPC: G01N33/53
Filed: 2007-05-25
Abstract: La présente invention concerne les signatures d'activation et d'expression de protéines ainsi que des procédés d'obtention et d'utilisation de telles signatures d'activation et d'expression de protéines aux fins de classification, de pronostic et d'encadrement thérapeutique pour le cancer. Une signature d'activation et d'expression de protéines peut être formée au moyen d'un processus qui consiste à analyser une pluralité d'échantillons avec un réseau protéique, à grouper les échantillons analysés sur la base de modèles et à générer une carte thermique.
Patent EP-2038973-A1 (EP)
Inventor: RAMOND ALAIN
IPC: H01T13/40
Filed: 2007-06-28
Abstract: The spark plug comprises: —a central electrode (2), —an insulating core (6) bearing the central electrode (2), —an external body (8) in which the insulating core (6) is mounted and which has a region (18) where the external body (8) is crimped onto the insulating core (6), and—a force sensor (30). The force sensor (30) is mounted at the periphery of the external body (8) between, on the one hand, a bearing element (38) secured to a first peripheral region of the external body (8) and, on the other hand, a second peripheral region (24) of the external body (8). The second peripheral region (24) of the external body (8) is further away from the crimping region (18) than the first peripheral region. The bearing element (38) is prestressed against the force sensor (30).
Patent EP-2054661-A1 (EP)
Title: Illuminating device comprising a lamp and a reflector
Inventor: BECK MARTIN
IPC: G02F1/13357
Filed: 2007-11-06
Abstract: The invention relates to an illuminating device comprising a lamp (3, 3', 3'') and a reflector (2, 2', 2''), wherein a reflecting surface (21, 22; 21', 22'; 21'', 22'') of the reflector (2, 2', 2'') is at least partly designed as the involute of a part element of the lamp (3, 3', 3'').
Patent EP-2115819-A1 (EP)
Inventor: BUSCH GEORG
IPC: H01R12/52
Filed: 2007-11-22
Abstract: The invention relates to a contact system comprising a spring and an accordingly associated printed circuit board surface, with which the spring is in contact. The printed circuit board surface to be contacted is a carbon printed circuit board surface. Increased contact resistance between the spring and the carbon printed circuit board surface, which is associated with the contact system according to the invention, is furthermore compensated for by electric and/or electronic means. The spring that is used is provided with a spring force adapted to the carbon printed circuit surface.
Patent EP-2091488-A1 (EP)
Title: Articles absorbants comprenant un dispositif de signalisation de fluide corporel
Inventor: NHAN DAVIS DANG H
IPC: A61F13/42
Filed: 2007-10-10
Abstract: Des indicateurs d'humidité peuvent comprendre des dispositifs d'alerte qui sont mis au point pour aider des parents ou assistants à identifier une condition de couche humide de façon précoce. Ces dispositifs produisent un signal soit visuel soit audible. Beaucoup de ces dispositifs reposent sur l'électronique, ce qui peut augmenter le coût de l'article absorbant. En outre, les dispositifs électroniques reposent sur des sources électriques et peuvent être sujets à une défaillance s'ils ne sont pas utilisés pendant une période de temps prolongée. L'invention concerne un dispositif de signalisation qui n'augmente pas de façon appréciable le coût de l'article absorbant, tout en fournissant un signal significatif (par exemple, une indication visible du temps passé depuis l'accident) au personnel soignant sans reposer sur une source électrique pour le fonctionnement.
Patent EP-2188297-A1 (EP)
Inventor: KAMAL AHMED
IPC: C07H15/26
Filed: 2007-10-26
Abstract: The present invention provides pyrrolo[2,1-c][1,4]benzodiazepine-glycoside prodrug of general formula 1a-b, useful as selective anticancer agents. The present invention also provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine-glycoside prodrugs of general formula 1a-b. This invention also provides activation of these prodrugs by E.coli β galactosidase and envisaged that these molecules are toxic to human cancer cell lines in the presence of the enzyme E.coli β-galactosidase. The prodrugs 1a and 1b were also found to be toxic to human cancer HepG2 cells even in the absence of the E.coli β-galactosidase. The toxic effect of the molecules when activated was similar to that of the parent molecules 6a and 6b, respectively.
Patent EP-2088428-A1 (EP)
Inventor: TANIGUCHI TATSUO
IPC: C08F2/44
Filed: 2007-10-16
Abstract: A process for producing polymer particles having an antigen or an antibody introduced into the surface thereof, by carrying out miniemulsion polymerization using a monomer, a radical polymerization initiator, an emulsifier, and a hydrophobe in the presence of the antigen or antibody to thereby produce the polymer particles, is disclosed. According to the process, it is possible to provide a reagent for immunological analysis having an excellent detection sensitivity and capable of avoiding a nonspecific reaction which occurs in conventional methods.
Patent EP-2094277-A1 (EP)
Inventor: KIM SOO-YOUL
IPC: A61K31/7028
Filed: 2007-10-19
Abstract: Disclosed herein is a novel use of glucosamine or a derivative thereof. A pharmaceutical composition for treating atopic dermatitis comprising glucosamine or a derivative thereof and a method of treating atopic dermatitis using the composition are disclosed. The pharmaceutical composition and the method realize the safe treatment of atopic dermatitis without the side effects associated with conventional anti-inflammatory drugs.
Patent EP-2089798-A1 (EP)
Inventor: NUMMELIN JUSSI
IPC: G06F9/48
Filed: 2007-11-09
Abstract: An application executing apparatus comprising at least one execution resource configured to execute at least one application is disclosed. The apparatus is provided with at least one processor configured to detect events triggering execution of the at least one application and to dynamically control use of the at least one execution resource in handling of the detected events based on a variable reflective of the operating conditions of the apparatus.
Patent EP-2125377-A1 (EP)
Inventor: WINTERAEKEN STEFAN A C J
IPC: B41J13/00
Filed: 2007-12-10
Abstract: An imaging system for processing a media includes a media transport path, an imaging station, a displacement device that controllably displaces the media along the media transport path relative to the imaging station, and a controller assembly. The controller assembly includes a feedback filter, a feedforward filter, a low-pass filter and a memory that stores and time delayed releases control data. During operation, the displacement device is actuated in response to an actuation command generated by the controller assembly. The actuation command has a feedback component based on a filtering by the feedback filter of an error signal including information about the position error between a desired and an actual position of the media and a feedforward component based on a time delayed, low-pass filtered, frequency dependent filtering of the error signal by the feedforward filter. The feedforward filter is configured such that the closed-loop controlled characteristics of the displacement device are compensated.
Patent EP-2094253-A1 (EP)
Inventor: SODERLING ERIC M
IPC: A61K31/095
Filed: 2007-12-08
Abstract: La présente invention concerne des comprimés solides ou des capsules de gel comprenant du paracétamol et un agent favorisant la production de glutathion qui atténue les effets hépatiques défavorables du paracétamol. L'activateur de la production de glutathion est de préférence de la n-acétyl cystéine ou un autre acide mercapto-2-amino alkyl carboxylique ayant des propriétés d'activation de la production de glutathion. Une composition préférée comprend du paracétamol (de 200 à 750 mg) et de la N-acétyl cystéine (de 200 à 600 mg). A la place et/ou en plus de la N-acétyl cystéine, la composition peut contenir au moins un produit choisi parmi la méthionine et la cystéine. Les compositions préférées peuvent contenir au moins un produit choisi parmi un opiacé (ou un équivalent synthétique), un antihistaminique, un antiémétique et un sédatif. L'encapsulation physique des ingrédients, facultativement avec ou à la place d'une fragrance, est utilisée pour rendre la composition plus acceptable pour les patients en atténuant les propriétés nocives de l'activateur de la production de glutathion. De préférence, les compositions sont préparées pour une auto-administration par le patient sous la forme d'un comprimé ou d'une capsule de gel, ce qui permet aux patients de prendre le médicament sans nécessiter la surveillance étroite d'un dispensateur de soins médicaux.
Patent EP-2094890-A1 (EP)
Inventor: BOERSTOEL HANNEKE
IPC: D06M15/285
Filed: 2007-11-19
Abstract: The invention relates to a method for obtaining high-tenacity aramid yarn, wherein the yarn is made of a copolymer obtained from a mixture of monomers comprising DAPBI, an aromatic para-diamine, and an aromatic para-diacid, wherein the yarn is heated in at least two process steps, characterized in that in a first step the yarn is heated at a temperature of 200 to 360° C. at a tension of at least 0.2 cN/dtex, followed by a second step wherein the yarn is heated at a temperature of 370 to 500° C. at a tension of less than 1 cN/dtex. The invention further pertains to a multifilament aramid yarn spun from a sulfuric acid spin dope and having a tenacity of at least 2500 mN/tex.
Patent EP-2223045-A1 (EP)
Inventor: TERTOOLEN SIMONE
IPC: G01C21/36
Filed: 2007-12-20
Abstract: La présente invention concerne un appareil de navigation (200) comportant une interface d'entrée (220, 240) conçue pour permettre à un utilisateur de sélectionner une destination, un processeur (210) et un affichage (240) commandé par le processeur. L'invention est caractérisée en ce que l'appareil de navigation (200) comprend en outre une mémoire (230) destinée aux données concernant les bâtiments, lesdites données concernant les bâtiments représentant la forme des bâtiments à chaque destination de la pluralité de destinations, et un module de génération de vue de destination (490) afin de générer, à partir des données concernant les bâtiments stockées dans ladite mémoire (230) pour ladite destination sélectionnée par l'utilisateur, une représentation tridimensionnelle d'un bâtiment à ladite destination sélectionnée par l'utilisateur, ledit processeur (210) réagissant audit module de génération de vue de destination (490) afin de commander ledit affichage (240) pour qu'il affiche ladite représentation tridimensionnelle à l'attention dudit utilisateur.
Patent EP-2101965-A1 (EP)
Inventor: MODOLO LUCIO
IPC: B26B21/22
Filed: 2007-12-20
Abstract: A razor (1) comprising a handle (2) provided with a support (3) with which a cylindrical head (7), provided with blades (8) arranged along a generatrix, is associated so that it can rotate selectively.
Patent EP-2114901-A1 (EP)
Title: Pyrimidines substituées en position 6 inhibant le vih
Inventor: GUILLEMONT JEROME EMILE GEORGES
IPC: C07D403/06
Filed: 2007-12-28
Abstract: L'invention porte sur des inhibiteurs de la réplication du VIH, représentés par la formule R1 représente l'hydrogène ; l'aryle ; le formyle ; l'(alkyl en C1-6)-carbonyle ; l'alkyle en C1-6 ; l'(alkyloxy en C1-6)-carbonyle ; R2, R3, R6 et R7 représentent l'hydrogène ; l'hydroxy ; le halo ; le cycloakyle en C3-7 ; l'alkyloxy en C1-6 ; le carboxyle ; l'(alkyloxy en C1-6)-carbonyle ; le cyano ; le nitro ; l'amino ; le mono- ou di(alkyl en C1-6)-amino ; le polyhaloalkyle en C1-6 ; le polyhaloalkyloxy en C1-6 ; -C(=O)R9 ; l'alkyle en C1-6, l'alcényle en C2-6 ou l'alcynyle en C2-6 facultativement substitués ; R4 et R8 représentent l'hydroxy ; le halo ; le cycloalkyle en C3-7 ; l'alkyloxy en C1-6 ; le carboxyle ; l'(alkyloxy en C1-6)-carbonyle ; le formyle ; le cyano ; le nitro ; l'amino ; le mono- ou di(alkyl en C1-6)amino ; le polyhaloalkyle en C1-6 ; le polyhaloalkyloxy en C1-6 ; -C(=O)R9 ; le cyano ; -S(=O)rR9 ; -NH-S(=O)2R9 ; -NHC(=O)H ; -C(=O)NHNH2 ; -NHC(=O)R9 ; Het ; -Y-Het ; alkyle en C1-6, l'alcényle en C2-6 ou alcynyle en C2-6 facultativement substitués ; R5 représente le pyridyle, -C(=O)NR5aR5b ; -CH(OR5c)R5d ; -CH2-NR5eR5f ; -CH=NOR5a ; -CH2-O-(alcényle en C2-6) ; -CH2-O-P(=O)(OR5g )2; -CH2-O-C(=O)-NH2 ; -C(=O)-R5d ; X représente -NR1-, -O-, - CH2-, -S- .  L'invention porte également sur des compositions pharmaceutiques contenant ces composés comme ingrédient actif, et sur des procédés de préparation desdits composés et desdites compositions.
Patent EP-2142670-A1 (EP)
Title: Profilage d'expression génique pour l'identification, la surveillance et le traitement du cancer du sein
Inventor: WASSMANN KARL
IPC: C12Q1/68
Filed: 2007-11-06
Abstract: L'invention porte sur divers modes de réalisation pour déterminer un ensemble de données de profil pour un sujet présentant un cancer du sein ou des conditions se rapportant à un cancer du sein sur la base d'un échantillon provenant du sujet, l'échantillon fournissant une source d'ARN. Le procédé comprend l'utilisation de l'amplification pour la mesure de la quantité d'ARN correspondant à au moins 1 constituant des Tableaux 1-5. L'ensemble de données de profil comprend la mesure de chaque constituant, et une amplification est effectuée dans des conditions de mesure qui peuvent être répétées de façon substantielle.
Patent EP-2127151-A1 (EP)
Title: Interrogation adaptative pour trafic hertzien de données en rafales
Inventor: VENKATACHALAM MUTHAIAH
IPC: H04W74/06
Filed: 2007-12-17
Abstract: Différents modes de réalisation de l'invention peuvent comprendre une interrogation adaptative dans un réseau hertzien, une ou plusieurs interrogations consécutives montrant que la station interrogée n'a pas de données à émettre. Lorsque l'exécution d'une interrogation adaptative est déclenchée, une station de base peut attendre pendant des intervalles de temps de plus en plus longs entre les interrogations jusqu'à une station d'abonné particulière, jusqu'à ce qu'un certain intervalle maximal soit atteint. Dans certains modes de réalisation, les intervalles peuvent augmenter de manière exponentielle.
Patent EP-1975672-A1 (EP)
Inventor: YASUNARI MATSUKAWA
IPC: G02B21/00
Filed: 2008-03-26
Abstract: Easy and optimum adjustment can be made by eliminating the user operation that requires him/her to understand the relationship between, on the one hand, a magnification of an objective lens (6) and a deflection angle of illumination light deflected by scanning device (3), and the other hand, the total magnification on the basis of the magnification of the objective lens (6) and the deflection angle of the illumination light deflected by the scanning device (3). The invention provides a scanning microscope (1) including an objective lens (6) for focusing illumination light onto a specimen (A); scanning device (3) for deflecting and scanning the illumination light; a pupil-projection optical system (4) for illuminating a pupil of the objective lens (6) with the illumination light scanned by the scanning device (3); a total-magnification specifying unit (15) for specifying a total magnification, an optical-system selecting unit (13,27) for changing at least one of the objective lens (6) and the pupil-projection optical system (4) in such a manner that a magnification of an optical system including the objective lens (6) and the pupil-projection optical system (4) is equal to or less than the total magnification specified by the total-magnification specifying unit (15) and that the numerical aperture of the optical system is maximized; and a deflection-angle determination unit (15-19) for determining a deflection angle of the illumination light deflected by the scanning device (3) on the basis of the ratio of the magnification of the optical system to the total magnification so as to achieve the total magnification.
Patent EP-2082700-A1 (EP)
Inventor: SCHMIDT MARTIN DR
IPC: G02B7/00
Filed: 2008-04-11
Abstract: The assembly has a surgical microscope (11) including an eyepiece lens (15), and a display unit (17) including a screen (18) i.e. touch screen. The display unit is designed to receive external information e.g. text, from a computer (20) and to display the information on the screen. The screen is arranged at a horizontal distance (d) to a vertical axis (9) extending by the eyepiece lens, where the distance is not larger than 30 centimeters. The screen is arranged above the lens. The display unit is fastened to a suspension (12) of the microscope. A control panel is integrated in the screen.
Patent EP-2113742-A1 (EP)
Inventor: BRUEGGER PETER
IPC: G01D5/14
Filed: 2008-04-30
Abstract: The device has a magnetic sensor (3) detecting magnetic field of a magnetic field generating device stationary with respect to a rotating shaft (2). An optical sensor (4) detects light emitted from a light source (6) i.e. LED, where the light is reflected or transmitted by an encoder disk (5) that is stationary with respect to the shaft. A signal processing unit receives data from the magnetic sensor unit and another data from the optical sensor, and determines an angle of rotation of the shaft from the received data, and/or determines the angle of rotation of the shaft from the latter data. An independent claim is also included for a measuring device for determining a position and/or an angle of rotation of a body that carries out a translatory and/or a rotary motion, comprising detection unit.
Patent EP-2015255-A1 (EP)
Inventor: SEEHAUS TIMO
IPC: G06T11/20
Filed: 2008-05-02
Abstract: The method involves using a Bezier curve (9) to design a detected object from multiple distance detection values. The distance detection values are assigned to every detection line (1). The object positions (8) of the detected object are determined from given sensor positions by the outgoing detection lines and the distance detection values.
Patent EP-2008616-A1 (EP)
Inventor: GOTO HIROAKI
IPC: A61F2/04
Filed: 2008-06-27
Abstract: A stent system 1 has a stent 2 having a hole and at least an anchor 3 having an arm 33. The stent 2 has a cylindrical shape, in which a sheet is rolled, and a plurality of holes 13 are provided thereon. A grasping portion 33A at the distal end of the arm 33 of the anchor 3 can be inserted into the holes 13. A grasping force X of the grip 3 is greater than a drag R that the holes of the stent 2 yield. The grip 3 deforms the stent 2, easily grasps the stent 2 and a biological tissue, whereby it is possible to fix the stent 2. In accordance with the present invention, it is possible to reliably fix the stent in a hollow organ.
Patent EP-2143953-A1 (EP)
Inventor: VEDSTED PER FROST
IPC: F04D1/06
Filed: 2008-07-10
Abstract: The assembly has a housing formed of two metallic housing parts (2) and a diffuser (12) is arranged in the housing. The diffuser is fixed between the housing parts in an axial direction (X). The housing parts are directly or indirectly in metallic contact with one another in such a manner that a force transmission in the axial direction between the housing parts is effected via elements of metal. The diffuser comprises a metallic element (14), which is clamped between an axial end (18) of the housing parts. The diffuser is made of metal or plastic.
Patent EP-2023432-A1 (EP)
Inventor: SUGITA NARUTOSHI
IPC: H01M50/77
Filed: 2008-08-07
Abstract: A fuel cell (10) according to the present invention includes a power generation unit (12). The power generation unit (12) is formed by stacking a first metal separator (14), a first membrane electrode assembly (16a), a second metal separator (18), a second membrane electrode assembly (16b), and a third metal separator (20). The number of flow grooves in a first oxygen-containing gas flow field (34) is different from the number of flow grooves in a second oxygen-containing gas flow field (48). The first oxygen-containing gas flow field (34) and the second oxygen-containing gas flow field (48) have the same length, and the flow grooves in the first oxygen-containing gas flow field (34) and the flow grooves in the second oxygen-containing gas flow field (48) have the same depth.
Patent EP-2164033-A1 (EP)
Inventor: REGGIO ELENA
IPC: G06Q10/00
Filed: 2008-08-28
Abstract: Method for selecting equipment resources in a manufacturing process, comprising the steps of creating an execution equipment list by retrieving out of a database one execution equipment (5) required for starting a process segment (4), retrieving out of the database a list of available sub-equipments of the execution equipment (5), checking within the list of sub-equipments an availability of each of a totality of required equipments (6) for each of a totality of work segments of the process segment (4) respectively, selecting the execution equipment (5) for the starting of the process segment (4), selecting each of the required equipments (6) for execution of each of the work segments respectively, in case the required equipment (6) for the work segment is available, creating an output list containing information about assignments of each of the required equipments (6) to each of the work segments respectively in case all of the required equipments (6) are available.
Patent EP-2165755-A1 (EP)
Inventor: RIZZI ENRICO
IPC: B01J8/02
Filed: 2008-09-23
Abstract: An isothermal chemical reactor (1) comprising an array of radially arranged plate-like heat exchange elements (11) inside a reaction space, each element comprising feeding and collecting ducts and a bundle of parallel tubes (15) defining channels (12) for a heat exchange medium, the tubes (15) having an elongated cross section and being disposed with a variable orientation relative to the radial direction of the reactor, so that inner tubes near the axis of the reactor have the cross-section major axis aligned with said radial direction, and outer tubes have the same axis perpendicular to the radial direction. The preferred structure of a plate-like heat exchange element is also disclosed.